Current therapeutic strategies for invasive and metastatic bladder cancer.

Onco Targets Ther · 2011 · PMC3143909 · PMID 21792316

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP = 0.06so close (0.05 < p ≤ 0.1)

Patients who received M-VAC showed a trend towards improvement in median OS (77 vs 46 months, P = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.